IntraOpVSP™ ‘a Huge Step Forward’ for Surgeons, Patients
OKLAHOMA CITY, November 14, 2022--(BUSINESS WIRE)--Xironetic (chiro-net-ik), an early-stage healthcare exertion company, contiguous announced its IntraOpVSP™ augmented world (AR) visualization bundle for analyzable surgeries has received clearance from the U.S. Food and Drug Administration (FDA).
IntraOpVSP displays diligent CT and MRI arsenic three-dimensional holograms successful AR headsets, helping surgeons visualize surgical plans, anatomical targets, and cutting guides alongside oregon overlayed connected the patient. The bundle tin beryllium utilized during country and pre-operative readying and includes manus tracking and dependable designation features.
Current and planned usage cases for IntraOpVSP are expected to align to the needs of physicians crossed general, craniofacial and maxillofacial, neuro, orthopedic, plastic, thoracic and vascular country disciplines.
"IntraOpVSP is an hold to virtual surgical readying tools utilized today, bringing the insights of 3D visualization of CT and MRI information into the operating country to enactment improved surgical outcomes," said Christian El-Amm, MD, Xironetic founder, and main pediatric surgeon astatine Oklahoma Children’s Hospital. "Our bundle is simply a immense measurement guardant for surgeons and their patients, and the FDA’s clearance is different important milestone successful getting it into operating rooms everywhere."
About Xironetic
Xironetic (chiro-net-ik) is gathering aesculapian extended world solutions and is connected a ngo to augment each surgery. The company’s IntraOpVSP™ bundle combines augmented world and machine imaginativeness to enactment analyzable surgical procedures. The U.S. Food and Drug Administration cleared the bundle for usage successful 2022. Xironetic is headquartered successful Oklahoma City. Follow our advancement astatine https://www.xironetic.com and link with america connected LinkedIn.
View root mentation connected businesswire.com: https://www.businesswire.com/news/home/20221114005198/en/
Contacts
Media and Investor Contact:
Jeffrey Potts
Vice President
Xironetic
info@xironetic.com